Bank of Nova Scotia
TBPH icon

Bank of Nova Scotia’s Theravance Biopharma TBPH Stock Holding History

Bank of Nova Scotia’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,649
Closed -$199K – 1205
2025
Q4 		$199K Buy
+10,649
New +$177K ﹤0.01% 1041
2022
Q2 		– Sell
-21,652
Closed -$207K – 1265
2022
Q1 		$207K Sell
21,652
-3,831
-15% -$37.5K ﹤0.01% 1148
2021
Q4 		$282K Buy
+25,483
New +$222K ﹤0.01% 1155

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return